Accumulus launches live integration with Veeva RIM for seamless global regulatory collaboration.

Accumulus Technologies has launched the Accumulus Direct Connect for Veeva RIM, enabling real-time, in-workflow connectivity between Veeva RIM and the Accumulus platform. This integration allows life sciences companies to manage regulatory interactions within Veeva RIM while using Accumulus as a global conduit to health authorities, reducing duplication and speeding up therapy approvals. Early users like Amgen highlight improved efficiency and visibility in regulatory submissions. Accumulus plans to expand this integration further to support broader regulatory collaboration worldwide.